查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575726

心輸出量監測儀市場 - 2024-2031

Cardiac Output Monitors Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球心輸出量監測儀市場規模達15億美元，預計2031年將達22.3億美元，2024-2031年預測期間複合年成長率為5.2%。

心輸出量監測儀在臨床醫學中發揮著至關重要的作用，特別是在重症監護和心臟病學環境中，因為它們提供有關患者心血管功能的重要資訊。心輸出量監測的重要性在於它能夠幫助醫療保健提供者就病患管理和治療做出明智的決策。心輸出量監測允許客製化患者治療策略。

透過根據患者的個別心血管需求調整治療方法，醫療專業人員可以最佳化患者的治療效果。心臟衰竭患者經常需要密切心輸出量監測，以評估治療效果並避免失代償。透過早期辨識和治療血流動力學不穩定，可以避免器官衰竭、組織缺氧和延長住院時間。

市場動態：

司機

心血管疾病盛行率增加

心血管疾病盛行率的上升推動了市場的成長。由於心血管疾病和病症的盛行率不斷上升，需要改進監測和管理技術，包括心輸出量監測器。由於心血管疾病的增加，市場正在迅速擴大。例如，根據美國疾病管制與預防中心的數據，心臟病是美國男性、女性以及大多數種族和族裔群體的首要死因。在美國，每 33 秒就有一人死於心血管疾病。美國約有 695,000 人死於心臟病，即每 5 個人中就有 1 人死於心臟病。

此外，根據英國心臟基金會2023 的數據，全球約有6.2 億人患有心臟病和循環系統疾病- 由於生活方式的改變、人口老齡化和人口成長以及心臟病生存率的提高，這一數字一直在上升和中風 - 如果這些趨勢持續下去，將會繼續上升。因此，心血管疾病的增加有助於推動市場的成長。此外，心血管輸出監測儀可以為醫療保健專業人員提供做出明智決策和避免負面結果所需的資訊，從而提高患者的安全性。監測技術的不斷發展使得開發侵入性更小、更精確的心輸出量監測工具成為可能，使其在臨床環境中更加可用和有用。

限制

心輸出量監測儀相關的高成本等因素預計將阻礙市場的發展。用於監測心輸出量的設備，尤其是侵入式設備，購買和操作起來都可能很昂貴。由於高昂的前期成本以及消耗品或校準的經常性成本，它們的使用可能會受到阻礙，特別是在資源有限的醫療保健環境中。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 心血管設備的普及率不斷提高
    • 限制
      • 與心輸出量監視器相關的高成本
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 未滿足的需求
  • PESTEL分析
  • 專利分析
  • SWOT分析

第 6 章：按類型

  • 有創心輸出量監測儀
  • 非侵入性心輸出量監測儀
  • 微創心輸出量監測儀
  • 其他

第 7 章：按技術

  • 肺動脈導管
  • 熱稀釋脈衝輪廓分析技術
  • 鋰稀釋技術
  • 動脈波形分析技術
  • 多普勒
  • 其他

第 8 章：最終用戶

  • 醫院
  • 心臟中心
  • 門診手術中心
  • 其他

第 9 章：按地區

  • 北美洲
    • 按配銷通路分類的規模分析和同比成長分析 (%)
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Edwards Lifesciences Corporation
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Masimo
  • Getinge Inc.
  • Nihon Kohden Corporation
  • Deltex Medical Group plc
  • GE Healthcare
  • Koninklijke Philips NV
  • Schwarzer Cardiotek
  • Tenko Medical System Corp
  • Osypka Medical (*LIST NOT EXHAUSTIVE)

第 12 章：附錄

簡介目錄
Product Code: MD7263

Overview

The global cardiac output monitors market reached US$ 1.5 billion in 2023 and is expected to reach US$ 2.23 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031.

Cardiac output monitors play a crucial role in clinical medicine, particularly in critical care and cardiology settings, as they provide essential information about a patient's cardiovascular function. The importance of cardiac output monitoring lies in its ability to help healthcare providers make informed decisions regarding patient management and treatment. Cardiac output monitoring allows patient treatment strategies to be customized.

By adapting therapies to a patient's individual cardiovascular needs, medical professionals can optimize patient outcomes. Close cardiac output monitoring is frequently necessary for patients with heart failure in order to evaluate the efficacy of treatment and avoid decompensation. Organ failure, tissue hypoxia, and extended hospital stays can all be avoided with the early identification and treatment of hemodynamic instability.

Market Dynamics: Drivers

Increasing prevalence of cardiovascular diseases

The rising prevalence of cardiovascular diseases propels the market growth. Improved monitoring and management technologies, including cardiac output monitors, are required due to the rising prevalence of cardiovascular diseases and disorders. The market is expanding rapidly as a result of the rise in cardiovascular diseases. For instance, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 33 seconds in the United States from cardiovascular disease. About 695,000 people in the United States died from heart disease, that's 1 in every 5 deaths.

Moreover, according to the British Heart Foundation 2023, stated that around 620 million people live with heart and circulatory diseases across the world - this number has been rising due to changing lifestyles, an aging, and growing population, and improved survival rates from heart attacks and strokes - and will continue to rise if these trends continue. Thus rising of the cardiovascular diseases helps to drive the market growth. Additionally, cardiovascular output monitors improve patient safety by giving healthcare professionals the information they need to make wise decisions and avoid negative outcomes. The development of less invasive and more precise cardiac output monitoring tools has been made possible by ongoing developments in monitoring technology, making them more available and useful in clinical settings.

Restraints

Factors such as high costs associated with cardiac output monitors are expected to hamper the market. The devices for monitoring cardiac output, particularly invasive ones, can be pricey for both purchase and operation. Their use may be hindered, especially in healthcare settings with limited resources, due to high upfront costs and recurring costs for consumables or calibration.

Segment Analysis

The global cardiac output monitors market is segmented based on type, technology, end-user, and region.

The non-invasive cardiac output monitors accounted for approximately 46.7% of the global cardiac output monitors market share.

The non-invasive cardiac output monitors segment is expected to hold the largest market share over the forecast period. In this segment, the features and launches of new products would drive this market.

A patient's cardiovascular function can be evaluated with non-invasive cardiac output monitors without a need for invasive treatments. These monitors offer useful data on cardiac output, or the amount of blood the heart pumps each minute, as well as other associated hemodynamic parameters. For instance, using invasive procedures like catheterization is not necessary when using non-invasive monitoring techniques like impedance cardiography or Doppler ultrasonography. As a result, there is a lower possibility of problems, infections, and patient discomfort brought on by invasive monitoring methods.

They aid in the early detection of abnormalities in the heart function of a patient. Clinicians can see problems like heart failure exacerbations or shock states and act quickly by continually monitoring cardiac output and associated metrics. Moreover, on April 25, 2022, with the addition of cardiac output, stroke volume, heart rate variability, and left ventricular ejection time to its VitalStream non-invasive patient monitoring platform, Caretaker Medical, a provider of wireless patient monitoring technologies, received FDA 510(k) clearance.

Geographical Analysis

North America accounted for approximately 43.8% of the global cardiac output monitors market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of cardiovascular diseases, approvals, and increase in the healthcare expenses in this region, help to propel the market.

For instance, according to the National Institute of Health, approximately 82.6 million people in the United States currently have one or more forms of cardiovascular disease (CVD), making it a leading cause of death for both men and women. Common types of cardiovascular disease include coronary heart disease (CHD), stroke, hypertension, and congestive heart failure. An estimated 16.3 million Americans aged 20 and older have CHD, a prevalence of 7 percent.

The prevalence for men is 8.3 percent and for women is 6.1 percent. About 7 million Americans aged 20 or older have had a stroke. Each year approximately 610,000 experience their first stroke and another 185,000 experience a recurrence. Approximately 87 percent of all strokes are ischemic of which 10 percent result from intracerebral hemorrhage and 3 percent result from subarachnoid hemorrhage.

Market Segmentation

By Type

Invasive Cardiac Output Monitors

Non-Invasive Cardiac Output Monitors

Minimally Invasive Cardiac Output Monitors

Others

By Technology

Pulmonary Artery Catheter

Thermodilution Pulse Contour Analysis Technique

Lithium Dilution Technique

Arterial Waveform Analysis Technique

Doppler

Others

By End-User

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Competitive Landscape

The major global players in the global cardiac output monitors market include Edwards Lifesciences Corporation, Masimo, Getinge Inc, Nihon Kohden Corporation, Deltex Medical Group plc, GE Healthcare, Koninklijke Philips N.V, Schwarzer Cardiotek, Tenko Medical System Corp, Osypka Medical among others.

Key Developments

In October 2023, Masimo announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO(R) board-in-cable (BIC) module. The LiDCO BIC module is designed to connect to multi-patient monitoring platforms, like the Masimo Root(R) Patient Monitoring and Connectivity Hub, to provide advanced hemodynamic monitoring. With this solution, clinicians can easily add LiDCO hemodynamic monitoring

In April 2023, French medical device company, Vygon India launched its advanced hemodynamic monitoring system, Mostcare Up, in North India during a Society of Critical Care Medicine (ISCCM) symposium in Chandigarh. The Mostcare Up system is a minimally invasive arterial pressure-based monitor powered by a patented algorithm based on the Pressure Recording Analytical Method (PRAM). It is the only monitor that can follow even the slightest hemodynamic variations in real time and from beat to beat.

Why Purchase the Report?

To visualize the global cardiac output monitors market segmentation based on type, technology, end-user, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global cardiac output monitors market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global cardiac output monitors market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Technology
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Cardiovascular Devices
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost Associated with the Cardiac Output Monitors
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Invasive Cardiac Output Monitors *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Invasive Cardiac Output Monitors
  • 6.4. Minimally Invasive Cardiac Output Monitors
  • 6.5. Others

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Pulmonary Artery Catheter *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Thermodilution Pulse Contour Analysis Technique
  • 7.4. Lithium Dilution Technique
  • 7.5. Arterial Waveform Analysis Technique
  • 7.6. Doppler
  • 7.7. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cardiac Centers
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Edwards Lifesciences Corporation *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Masimo
  • 11.3. Getinge Inc.
  • 11.4. Nihon Kohden Corporation
  • 11.5. Deltex Medical Group plc
  • 11.6. GE Healthcare
  • 11.7. Koninklijke Philips N.V
  • 11.8. Schwarzer Cardiotek
  • 11.9. Tenko Medical System Corp
  • 11.10. Osypka Medical (*LIST NOT EXHAUSTIVE)

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us